propylthiouracil PTU
Selected indexed studies
- Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis. (PLoS One, 2023) [PMID:37205692]
- The propylthiouracil dilemma. (Curr Opin Endocrinol Diabetes Obes, 2012) [PMID:22820213]
- Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. (Nat Rev Nephrol, 2012) [PMID:22664738]
_Worker-drafted node — pending editorial review._
Connections
propylthiouracil PTU is a side effect of
Sources
- Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis. (2023) pubmed
- The propylthiouracil dilemma. (2012) pubmed
- Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. (2012) pubmed
- Propylthiouracil (PTU) pharmacology in the rat. I. Serum and thyroid PTU measurements by radioimmunoassay. (1983) pubmed
- Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function. (1983) pubmed
- SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2020) pubmed
- Teratogen update: Antithyroid medications. (2020) pubmed
- Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis. (2007) pubmed
- Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity. (2014) pubmed
- Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: A meta-analysis. (2022) pubmed